Rhinomed Wins FDA Approval For Nasal Dilator

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Rhinomed’s (ASX:RNO) sport technology the Turbine was granted registration with the US Food and Drug Administration as a medical device.

The Turbine™ is an internal nasal dilator that increases airflow by an average of 38% and can assist athletes as a solution to breathlessness during aerobic exercise.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC